These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
317 related articles for article (PubMed ID: 2502419)
21. Perforin expression can define CD8 positive lymphocyte subsets in pigs allowing phenotypic and functional analysis of natural killer, cytotoxic T, natural killer T and MHC un-restricted cytotoxic T-cells. Denyer MS; Wileman TE; Stirling CM; Zuber B; Takamatsu HH Vet Immunol Immunopathol; 2006 Apr; 110(3-4):279-92. PubMed ID: 16325923 [TBL] [Abstract][Full Text] [Related]
22. The expression and functional involvement of laminin-like molecules in non-MHC restricted cytotoxicity by human Leu-19+/CD3- natural killer lymphocytes. Schwarz RE; Hiserodt JC J Immunol; 1988 Nov; 141(10):3318-23. PubMed ID: 3263421 [TBL] [Abstract][Full Text] [Related]
23. Phenotypic and functional characterization of recombinant interleukin 2 (rIL 2)-induced activated killer cells: analysis at the population and clonal levels. Ferrini S; Miescher S; Zocchi MR; von Fliedner V; Moretta A J Immunol; 1987 Feb; 138(4):1297-302. PubMed ID: 3100633 [TBL] [Abstract][Full Text] [Related]
24. The relationship of CD16 (Leu-11) and Leu-19 (NKH-1) antigen expression on human peripheral blood NK cells and cytotoxic T lymphocytes. Lanier LL; Le AM; Civin CI; Loken MR; Phillips JH J Immunol; 1986 Jun; 136(12):4480-6. PubMed ID: 3086432 [TBL] [Abstract][Full Text] [Related]
25. Lymphokine-activated killer activity induced by in vivo interleukin 2 therapy: predominant role for lymphocytes with increased expression of CD2 and leu19 antigens but negative expression of CD16 antigens. Weil-Hillman G; Fisch P; Prieve AF; Sosman JA; Hank JA; Sondel PM Cancer Res; 1989 Jul; 49(13):3680-8. PubMed ID: 2471587 [TBL] [Abstract][Full Text] [Related]
26. Enrichment in tumor-reactive CD8+ T-lymphocytes by positive selection from the blood and lymph nodes of patients with head and neck cancer. Letessier EM; Heo DS; Okarma T; Johnson JT; Herberman RB; Whiteside TL Cancer Res; 1991 Aug; 51(15):3891-9. PubMed ID: 1677310 [TBL] [Abstract][Full Text] [Related]
27. T cell clones expressing the natural killer cell-related p58 receptor molecule display heterogeneity in phenotypic properties and p58 function. Ferrini S; Cambiaggi A; Meazza R; Sforzini S; Marciano S; Mingari MC; Moretta L Eur J Immunol; 1994 Oct; 24(10):2294-8. PubMed ID: 7925558 [TBL] [Abstract][Full Text] [Related]
28. IL-4 inhibits IL-2-mediated induction of human lymphokine-activated killer cells, but not the generation of antigen-specific cytotoxic T lymphocytes in mixed leukocyte cultures. Spits H; Yssel H; Paliard X; Kastelein R; Figdor C; de Vries JE J Immunol; 1988 Jul; 141(1):29-36. PubMed ID: 2454260 [TBL] [Abstract][Full Text] [Related]
29. A monoclonal antibody reactive with a 15-kDa cytoplasmic granule-associated protein defines a subpopulation of CD8+ T lymphocytes. Anderson P; Nagler-Anderson C; O'Brien C; Levine H; Watkins S; Slayter HS; Blue ML; Schlossman SF J Immunol; 1990 Jan; 144(2):574-82. PubMed ID: 2104899 [TBL] [Abstract][Full Text] [Related]
30. Phenotypic and functional characterization of human T cell clones. Patel SS; Duby AD; Thiele DL; Lipsky PE J Immunol; 1988 Dec; 141(11):3726-36. PubMed ID: 2846692 [TBL] [Abstract][Full Text] [Related]
31. CD3/Ti gamma A: a functional gamma-receptor complex expressed on human peripheral lymphocytes. Faure F; Jitsukawa S; Triebel F; Hercend T J Immunol; 1988 Mar; 140(5):1372-9. PubMed ID: 2964471 [TBL] [Abstract][Full Text] [Related]
32. A novel surface molecule expressed by long-term cultured T and natural killer cells is involved in cell activation. Ferrini S; Cantoni C; Ciccone E; Biassoni R; Prigione I; Bottino C; Venzano P; Moretta L Eur J Immunol; 1991 Sep; 21(9):1981-7. PubMed ID: 1832383 [TBL] [Abstract][Full Text] [Related]
33. T cell nature of some lymphokine-activated killer (LAK) cells. Frequency analysis of LAK precursors within human T cell populations and clonal analysis of LAK effector cells. Moretta L; Pende D; Cozzani R; Merli A; Bagnasco M; Mingari MC Eur J Immunol; 1986 Dec; 16(12):1623-5. PubMed ID: 3102249 [TBL] [Abstract][Full Text] [Related]
34. Functional and phenotypic differences between CD4+ and CD4- T cell receptor-gamma delta clones from peripheral blood. Spits H; Paliard X; Vandekerckhove Y; van Vlasselaer P; de Vries JE J Immunol; 1991 Aug; 147(4):1180-8. PubMed ID: 1831219 [TBL] [Abstract][Full Text] [Related]
35. Characterization of human autotumor-reactive T-cell clones obtained from tumor-infiltrating lymphocytes in liver metastasis of gastric carcinoma. Shimizu Y; Weidmann E; Iwatsuki S; Herberman RB; Whiteside TL Cancer Res; 1991 Nov; 51(22):6153-62. PubMed ID: 1718596 [TBL] [Abstract][Full Text] [Related]
36. Characterization of the cytolytic activity of CD4+ and CD8+ tumor-infiltrating lymphocytes in human renal cell carcinoma. Finke JH; Rayman P; Alexander J; Edinger M; Tubbs RR; Connelly R; Pontes E; Bukowski R Cancer Res; 1990 Apr; 50(8):2363-70. PubMed ID: 2107973 [TBL] [Abstract][Full Text] [Related]
37. Murine thymic nurse cell clone supports the growth of fetal thymocytes in the presence of interleukin 2. Doi H; Nakagawa S; Nagata K; Hata M; Kasahara S; Sakata T; Suzuki R; Nanno M; Sugamura K; Itoh T Eur J Immunol; 1991 Mar; 21(3):783-92. PubMed ID: 1672648 [TBL] [Abstract][Full Text] [Related]
38. Long-term interleukin 2-dependent growth and cytotoxic activity of tumor-infiltrating lymphocytes from human squamous cell carcinomas of the head and neck. Heo DS; Whiteside TL; Johnson JT; Chen KN; Barnes EL; Herberman RB Cancer Res; 1987 Dec; 47(23):6353-62. PubMed ID: 3315186 [TBL] [Abstract][Full Text] [Related]
39. Clonal analysis of human CD4-CD8-CD3- thymocytes highly purified from postnatal thymus. Hori T; Spits H J Immunol; 1991 Apr; 146(7):2116-21. PubMed ID: 1826017 [TBL] [Abstract][Full Text] [Related]
40. Phenotypic study of CD4+ and CD8+ lymphocyte subsets in relation to cytomegalovirus carrier status and its correlate with pokeweed mitogen-induced B lymphocyte differentiation. Gratama JW; Langelaar RA; Oosterveer MA; van der Linden JA; den Ouden-Noordermeer A; Naipal AM; Visser JW; de Gast GC; Tanke HJ Clin Exp Immunol; 1989 Aug; 77(2):245-51. PubMed ID: 2476271 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]